Logo main
  • 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け
  • Icon us

特許

68,020 件
全IP種別
PATENTFIELDで検索
IPを掲載
係属中

Electrospray ionization dev...

Electrospray ionization (ESI) is a technique used in mass spectrometry to produce ions using an electrospray in which a high voltage is applied to a liquid to create an aerosol. It is especially us...

係属中

Sensor grid

A sensor grid integrates wireless sensor networks with grid computing concepts to enable real-time sensor data collection and the sharing of computational and storage resources for sensor data proc...

権利維持

Nanoparticle

Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and propertie...

係属中

Glucuronidase inhibitors

Glucuronidase inhibitors

係属中

Machining

Machining is any of various processes in which a piece of raw material is cut into a desired final shape and size by a controlled material-removal process. The processes that have this common theme...

権利維持

Photovoltaic system

A photovoltaic system, also solar PV power system, or PV system, is a power system designed to supply usable solar power by means of photovoltaics. It consists of an arrangement of several componen...

権利維持

Biofluid rheology

Rheology (/riːˈɒlədʒi/; from Greek ῥέω rhéō, "flow" and -λoγία, -logia, "study of") is the study of the flow of matter, primarily in a liquid state, but also as 'soft solids' or solids under condit...

係属中

Ischemia

Ischemia, also spelled as ischaemia or ischæmia[a] (/ɪˈskiːmiə/[1][2]), is a restriction in blood supply to tissues,[3] causing a shortage of oxygen and glucose needed for cellular metabolism (to k...

係属中

Microfluidic device

Microfluidics is a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, with practical applications to the design of systems in whi...

係属中

Tumor

Neoplasm (from Ancient Greek νεο- neo- "new" and πλάσμα plasma "formation, creation"), is an abnormal growth of tissue, and when also forming a mass is commonly referred to as a tumor or tumour.[1]...

係属中

Cryostorage

Cryopreservation or cryoconservation is a process where cells, whole tissues, or any other substances susceptible to damage caused by chemical reactivity or time are preserved by cooling to sub-zer...

権利維持

Nitric oxide-releasing xerogel

Nitric oxide-releasing xerogel

係属中

Laser vaporization of sutur...

Laser vaporization of suture impant

係属中

Food-grade protein matrices

Food-grade protein matrices

係属中

Volume phase holography dif...

Another method for manufacturing diffraction gratings uses a photosensitive gel sandwiched between two substrates. A holographic interference pattern exposes the gel which is later developed. These...

係属中

Factor IX

Factor IX (or Christmas factor) (EC 3.4.21.22) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. It was di...

係属中

Virtual research space

Virtual spaces can serve a variety of research and educational goals[31] and may be useful for examining human behaviour.[31] Offline- and virtual-world personalities differ from each other but are...

係属中

Tumor necrosis factor recep...

The tumor necrosis factor receptor superfamily (TNFRSF) is a group of cytokine receptors characterized by the ability to bind tumor necrosis factors (TNFs) via an extracellular cysteine-rich domain...

権利維持

Leukemia

Leukemia (American English) or leukaemia (British English) /luːˈkiːmiːə/[1] is a group of cancers that usually begins in the bone marrow and results in high numbers of abnormal white blood cells.[2...

権利維持

Phosphodiesterase IX inhibitor

A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messenger...

  • 最初
  • 前
  • …
  • 408
  • 409
  • 410
  • 411
  • 412
  • 413
  • 414
  • 415
  • 416
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

Icon us

Logo gray © 2025 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム